Aerospace and defense parts manufacturer Arxis (ARXS.US) has priced its IPO at $25-28 per share, aiming to raise over $1 billion.

Arxis Inc., a manufacturer of electronic and mechanical components for the aerospace, defense, medical technology, and professional industrial markets, is currently seeking to raise up to $1.06 billion in funds through an IPO on the US stock market. According to documents filed with the US Securities and Exchange Commission (SEC) on Wednesday, the company plans to issue 37.7 million shares at a price range of $25 to $28 per share. At the upper end of the price range, based on the number of outstanding shares listed in the filing, the company's market value would reach $11.2 billion. Supported by Arcline Investment Management, Arxis primarily serves the aerospace, defense, medical technology, and professional industrial markets by manufacturing electronic and mechanical components. With increasing defense budgets, Arxis' IPO aligns with investors' growing interest in defense demand and expenditure. In the US, the Trump administration is expected to prioritize new contractors as it strengthens and modernizes missile ammunition reserves. The filing shows that the defense and space sectors are Arxis' largest end markets, accounting for approximately 47% of its revenue in 2025; meanwhile, its commercial aerospace segment accounts for around 23% of revenue during the same period. According to the filing, the company achieved approximately $460 million in net income on $1.6 billion in revenue last year, while in 2024, it expects to generate $743 million in revenue with a net loss of $55 million. Arxis has over 5,000 customers, with about 90% of its revenue coming from patented products. The company's listing is expected to be one of the few IPOs in the US industrial sector this year, along with Aevex Corp. supported by Madison Dearborn Partners, and nuclear energy company X-Energy Inc. Goldman Sachs, Morgan Stanley, and Jefferies Financial Group are the main underwriters for this offering. The company anticipates its stock to be listed on the Nasdaq Global Select Market under the ticker symbol "ARXS."